September 30, 2016 3:24 PM ET


Company Overview of Paratek Pharmaceuticals, Inc.

Executive Profile

Michael F. Bigham CPA, MBA

Chairman of the Board and Chief Executive Officer, Paratek Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 17 different industries.

See Board Relationships
As of Fiscal Year 2015


Mr. Michael F. Bigham, also known as Mike, CPA, MBA serves as a Partner at Datron Systems, Inc. Mr. Bigham has been Chairman of the Board and Chief Executive Officer at Paratek Pharmaceuticals, Inc. since October 2014 served as its Executive Chair. Mr. Bigham served as an Executive Partner at Abingworth Bioventures III L.P.; Abingworth LLP; Abingworth Bioventures IV L.P. and Abingworth Bioventures V, L.P. from 2003 to 2015. Mr. Bigham joined Abingworth since 2002 and ...

Corporate Headquarters

75 Park Plaza
Boston, Massachusetts 02116

United States

Phone: 617-807-6600
Fax: 617-275-0039

Board Members Memberships

Chairman of the Board and Chief Executive Officer


University of Virginia
Stanford Graduate School of Business

Other Affiliations

Annual Compensation

Total Annual Compensation$348,958

Stocks Options

Restricted Stock Awards$1,288,500
All Other Compensation$10,852
Exercisable Options$16,667
Unexercisable Options$228,426
Total Number of Options$535,279

Total Compensation

Total Annual Cash Compensation$509,810
Total Short Term Compensation$348,958
Other Long Term Compensation$1,299,352
Total Calculated Compensation$3,199,310

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Paratek Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at